AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 59 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,985,677 | +218.4% | 534,159 | +75.2% | 0.00% | – |
| Q3 2022 | $2,508,000 | +57.8% | 304,800 | +25.8% | 0.00% | – |
| Q2 2022 | $1,589,000 | -40.9% | 242,300 | -49.6% | 0.00% | – |
| Q1 2022 | $2,687,000 | -62.9% | 480,853 | -68.8% | 0.00% | – |
| Q4 2021 | $7,234,000 | +62.6% | 1,542,396 | +114.2% | 0.00% | – |
| Q3 2021 | $4,450,000 | -0.8% | 720,062 | +5.8% | 0.00% | – |
| Q2 2021 | $4,484,000 | +6.7% | 680,370 | +18.5% | 0.00% | – |
| Q1 2021 | $4,202,000 | -22.9% | 574,111 | -39.2% | 0.00% | – |
| Q4 2020 | $5,452,000 | +67.0% | 944,818 | +71.9% | 0.00% | – |
| Q3 2020 | $3,265,000 | -4.3% | 549,743 | -17.0% | 0.00% | – |
| Q2 2020 | $3,410,000 | +101.3% | 662,055 | +41.5% | 0.00% | – |
| Q1 2020 | $1,694,000 | – | 467,812 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PATHWAY CAPITAL MANAGEMENT, LP | 245,606 | $3,671,810 | 6.55% |
| AIGH Capital Management LLC | 695,358 | $10,395,602 | 3.42% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 638,360 | $9,544 | 2.08% |
| Kellner Capital, LLC | 100,016 | $1,495 | 1.74% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,464,807 | $21,898,865 | 1.70% |
| Worth Venture Partners, LLC | 170,925 | $2,555,329 | 1.51% |
| Birchview Capital, LP | 100,000 | $1,495 | 1.06% |
| BCK CAPITAL MANAGEMENT LP | 68,000 | $1,016,600 | 1.05% |
| WATER ISLAND CAPITAL LLC | 698,915 | $10,449 | 0.89% |
| EHP Funds Inc. | 292,043 | $4,366 | 0.82% |